# Amexdrug Corporation (AXRX)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/AXRX/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 736.6K | $ 21.0K | N/A | $ 422.5K | $ 1.82M |
| 2025 | $ 2.28M | $ 31.0K | N/A | $ 431.3K | $ 1.80M |
| 2024 | $ 3.57M | $ 12.0K | N/A | $ 463.3K | $ 1.76M |
| 2023 | $ 4.23M | $ 38.7K | N/A | $ 491.4K | $ 1.75M |
| 2022 | $ 3.91M | $ 301.0K | N/A | $ 694.1K | $ 1.92M |
| 2021 | $ 5.73M | $ 88.2K | N/A | $ 814.7K | $ 1.65M |
| 2020 | $ 3.12M | $ -199.4K | N/A | $ 1.97M | $ 1.52M |
| 2013 | $ 3.1K | $ 81 | $ 208 | $ 961 | $ 658 |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.23 |
| Liabilities / Eq | 0.32 |
| Current Ratio | 15.30 |

## Debt coverage

| Indicator | Value |
| --- | --- |
| Gross Debt / Earnings | 17.52 |

## Other views

- [Metrics](https://sponda.capital/en/AXRX.md)
- [Charts](https://sponda.capital/en/AXRX/charts.md)
- [Compare](https://sponda.capital/en/AXRX/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.